Home » Topics » BioWorld Science

BioWorld Science
RSS

Adropin is correlated with erectile dysfunction in coronary artery disease patients

Aug. 16, 2019

IL-13Rlalpha2 as a therapeutic target in inflammatory bowel disease

Aug. 16, 2019

TNFR2 is yang to TNFR1's yin

Aug. 16, 2019

FDA clears Heat Biologics' IND for study of HS-130 plus HS-110

Aug. 14, 2019

Too much oxygen may be issue in Leigh syndrome

Aug. 14, 2019

European Commission approves ibrutinib for expanded use in two indications

Aug. 14, 2019

Enrollment ongoing in phase III study of tucatinib plus T-DM1 in HER2+ breast cancer

Aug. 14, 2019

DelMar reports updated results from phase II study of VAL-083 in newly diagnosed GBM

Aug. 14, 2019

CureVac, Yale to jointly discover mRNA-based candidates for pulmonary diseases

Aug. 14, 2019

AC Immune partners with University of Pennsylvania to further study TDP-43

Aug. 14, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...